Tempest announces $4.6 million registered direct offering of common stock; shares decline over 13%

• Tempest Therapeutics (NASDAQ:TPST) announced on Wednesday that it has entered into a definitive agreement with a single institutional investor for the purchase and sale in a registered direct offering of 739,000 shares of its common stock at an offering price